tiprankstipranks
Eliem Therapeutics (ELYM)
NASDAQ:ELYM
US Market

Eliem Therapeutics (ELYM) Ownership - Who Owns Eliem Therapeutics?

32 Followers

Eliem Therapeutics (ELYM) Ownership Overview

23.57%1.53%9.12%65.78%
23.57% Insiders
9.12% Other Institutional Investors
65.78% Public Companies and
Individual Investors
The ownership structure of Eliem Therapeutics (ELYM) stock is a mix of institutional, retail and individual investors. Approximately 10.65% of the company’s stock is owned by Institutional Investors, 23.57% is owned by Insiders and 65.78% is owned by Public Companies and Individual Investors.
The ownership structure of Eliem Therapeutics (ELYM) stock is a mix of institutional, retail and individual investors. Approximately 10.65% of the company’s stock is owned by Institutional Investors, 23.57% is owned by Insiders and 65.78% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,150,849Institution47.44%52,340,379
811,680Institution2.93%3,230,486
308,817Institution1.11%1,229,092
308,817Institution1.11%1,229,092
61,246Institution0.22%243,759
53,323Institution0.19%212,226
12,468Institution0.04%49,623
1,669Institution<0.01%6,643

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
308,817Institution1.11%1,229,092
61,246Institution0.22%243,759
53,323Institution0.19%212,226
1,669Institution<0.01%6,643

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
189,734Institution0.68%519,871
119,083Institution0.43%326,287
12,468Institution0.04%46,755

FAQ

Who Owns Eliem Therapeutics (ELYM)?
According to the latest TipRanks data, approximately 9.12% of the company's stock is held by institutional investors, 23.57% is held by insiders, and 65.78% is held by retail investors.
    What percentage of Eliem Therapeutics (ELYM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 9.12% of Eliem Therapeutics (ELYM) stock is held by institutional investors.
      What percentage of Eliem Therapeutics (ELYM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 65.78% of Eliem Therapeutics (ELYM) stock is held by retail investors.
        Who owns the most shares of Eliem Therapeutics (ELYM)?
        Peter Kolchinsky owns the most shares of Eliem Therapeutics (ELYM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis